Current Edition

Arena

After slower-than-expected review, Pfizer and Arena close buyout deal

Dive Brief: Arena Pharmaceuticals’ $7 billion sale to Pfizer closed on Friday, ending a slightly protracted regulatory review that raised questions about whether the deal would …

Continue Reading →